Generic name: HAEMOPHILUS INFLUENZAE TYPE B STRAIN 20,752 CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN 10ug in 0.5mL
Dosage form: injection, powder, lyophilized, for solution
Medically reviewed on December 18, 2017.
HIBERIX is to be reconstituted only with the accompanying saline diluent. The reconstituted vaccine should be a clear and colorless solution. Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. If either of these conditions exists, the vaccine should not be administered.
|Figure 1. Cleanse vial stopper. Attach appropriate needle to accompanying prefilled syringe of saline diluent and insert into vial.||Figure 2. Transfer entire contents of prefilled syringe into vial. With needle still inserted, vigorously shake the vial.||Figure 3. After reconstitution, withdraw entire contents of vial (approximately 0.5 mL) and administer by intramuscular injection.|
After reconstitution, HIBERIX should be administered promptly or stored refrigerated between 2° and 8°C and administered within 24 hours. If the vaccine is not administered promptly, shake the solution vigorously again before injection.
Dose and Administration
HIBERIX is administered as a single dose (approximately 0.5 mL) by intramuscular injection into the anterolateral aspect of the thigh or deltoid.
Do not administer this product intravenously, intradermally, or subcutaneously.
HIBERIX is to be used as a booster dose in children who have received a primary series with a Haemophilus b Conjugate Vaccine that is licensed for primary immunization [see Indications and Usage (1)].
More about Hiberix (haemophilus b conjugate (prp-t) vaccine)
- Hiberix Side Effects
- During Pregnancy
- Drug Interactions
- Pricing & Coupons
- En Español
- Drug class: bacterial vaccines
Other brands: ActHIB